James R. Copland is the director of the Manhattan Institute's Center for Legal Policy, which seeks to develop and communicate thoughtful ideas on how to improve the civil and criminal justice system. Copland oversees two of the Institute's websites, PointofLaw.com, a web magazine that brings together information and opinion on the U.S. litigation system, as well as the Institute's new corporate-governance website, ProxyMonitor.org. He is also project manager for the Institute's Trial Lawyers, Inc. series of publications examining the size, scope, and inner workings of America's lawsuit industry.
Copland has published opinion columns in national, local, and online newspapers, including The Wall Street Journal, The National Law Journal, Investors Business Daily, and USA Today. He has appeared on various television and radio shows, including those on PBS, FOX News, FOX Business, MSNBC, CNBC, C-SPAN, and NPR. He has testified before Congress and is a regular speaker and conference participant discussing tort reform issues.
Prior to joining the Manhattan Institute, Copland was a management consultant with McKinsey and Company in New York. He had earlier served as a law clerk for Ralph K. Winter on the United States Court of Appeals for the Second Circuit. He has been a director of two privately held manufacturing companies since 1997.
Copland received J.D. and M.B.A degrees from Yale, where he was an Olin Fellow in Law and Economics and an editor of the Yale Journal on Regulation. He also has an M.Sc. in politics of the world economy from the London School of Economics and a B.A. in economics with highest distinction and highest honors from the University of North Carolina at Chapel Hill, where he was a Morehead Scholar.
- PBS's "Newshour"
- Board Member's "This Week in the Boardroom"
- WABC's "John Batchelor Show"
- Westwood One's "Lars Larson Show"
- Money Radio's "Business for Breakfast"
- KPCC's "Airtalk"
- SBN's "Small Business Advocate"
- WBAL's "Ron Smith Show"
- WTPL's "Bulldog Live with Brian Tilton"
- 97.1 FM Talk's "Randy Tobler Show"
[SORT BY CATEGORY] [SORT BY PUBLICATION TYPE]
- Shareholder Activism and the 2013 Proxy Season, Boardmember.com, 03-11-13
- Why Does FDA Keep Drugmakers From Informing Doctors?, Investor's Business Daily, 01-09-13
- 'Magnet Courts' Attract Class Action Corruption, Washington Times, 11-23-12
- Minnesota Attorney General's Assault on American Health, Washington Examiner, 11-22-12
- Philadelphia Still in Need of Tort Reform, The Philadelphia Inquirer, 11-18-12
- Politicized Proxy Advisers vs. Individual Investors, Wall Street Journal, 10-07-12
- Politicized Proxy Advisers vs. Individual Investors, New York Post, 10-07-12
- Unions Target Corporations Through Shareholder Activism, Washington Examiner, 07-19-12
- 2012 Proxy Season: Results and Lessons for Directors, Boardmember.com, 07-16-12
- Don't Believe the Hype About Corporate Political Spending, Washington Examiner, 06-22-12
- More Articles >>
- Proxy Monitor 2013: Political Spending, Say on Pay, and Other Key Issues to Watch in the 2013 Proxy Season Proxy Monitor Report 5, March 2013
- Off-Label, Not Off-Limits: The Fda Needs To Create a Safe Harbor For Off-Label Drug Use Issue Brief 15, December 2012
- Cracked Justice: Philadelphia's Magnet Court Making Progress but in Need of Greater Reform Trial Lawyers Inc. Update 10, November 2012
- Proxy Monitor 2012: A Report on Corporate Governance and Shareholder Activism Proxy Monitor Report 4, September 2012
- The Shadow Regulatory State: The Rise of Deferred Prosecution Agreements Legal Policy Report 14, May 2012
- Shareholder Activism: What to Watch for in the 2012 Proxy Season Proxy Monitor Report 3, Winter 2012
- Proxy Monitor 2011: A Report on Corporate Governance and Shareholder Activism Proxy Monitor Report 2, Fall 2011
- New Database Reveals Shareholder Proposal Trends Proxy Monitor Report 1, Winter 2011
- Regulation by Prosecution: The Problems with Treating Corporations as Criminals Legal Policy Report 13, December 2010
- In the Wake of Wyeth v. Levine: Making the Case for FDA Preemption and Administrative Compensation Project FDA Report 1, March 2009
Trial Lawyers Inc. Industry Focus
Trial Lawyers Inc. State Focus
City Journal articles
- Laura Finn, web editor for BoardMember.com and James Copland discuss the results of ProxyMonitor.org's first finding in the 2013 Proxy Monitor season. , 04-16-13
- James Copland and Ted Frank, discuss the significance of the Supreme Court's recent ruling in Comcast v. Behrend and its potential impact on class action litigation., 04-08-13
- Jim Copland and Hester Pierce, senior fellow at the Mercatus Center, discuss her recent book co-authored with James Broughel, Dodd-Frank: What It Does and Why It Is Flawed., 01-31-13
- Nicholas Q. Rosenkranz, discusses the topic of his forthcoming book, the subjects and objects of the Constitution and their role in constitutional interpretation, with Jim Copland., 01-03-13
- James Copland and Adam Freedman, author of "The Naked Constitution", discuss the Supreme Court's ruling on the 5th amendment takings case, Arkansas Game and Fish v. United States., 12-11-12
- James Copland and Adam Freedman, author of "The Naked Constitution," discuss oral arguments from the recent Supreme Court hearing of Fisher v. University of Texas., 10-16-12
- James Copland and Adam Freedman, author of The Naked Constitution: What the Founders Said, and Why it Still Matters, discuss the legacy of judicial activism and the "Living Constitution" theory., 10-16-12
- James Copland and Collin Levy, senior editorial page writer at the Wall Street Journal, discuss findings from "Proxy Monitor 2012: A Report on Corporate Governance and Shareholder Activism.", 10-08-12
- Isaac Gorodetski, project manager of the Manhattan InstituteĂ¯Â¿Â½s Center for Legal Policy interviews the CenterĂ¯Â¿Â½s director, James Copland, about his latest Proxy Monitor report and shareholder , 07-12-12
- Nadine Strossen, Professor of Law at New York Law School, discusses nuances of the Obamacare decision with Jim Copland., 06-28-12
- More Podcasts >>